228 related articles for article (PubMed ID: 12647307)
1. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
[TBL] [Abstract][Full Text] [Related]
3. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
Sahara T; Itoh K; Debari K; Sasaki T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
[TBL] [Abstract][Full Text] [Related]
4. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle.
Lehenkari PP; Laitala-Leinonen T; Linna TJ; Väänänen HK
Biochem Biophys Res Commun; 1997 Jun; 235(3):838-44. PubMed ID: 9207248
[TBL] [Abstract][Full Text] [Related]
5. Bafilomycin A1 Attenuates Osteoclast Acidification and Formation, Accompanied by Increased Levels of SQSTM1/p62 Protein.
Zhu S; Rea SL; Cheng T; Feng HT; Walsh JP; Ratajczak T; Tickner J; Pavlos N; Xu HZ; Xu J
J Cell Biochem; 2016 Jun; 117(6):1464-70. PubMed ID: 27043248
[TBL] [Abstract][Full Text] [Related]
6. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
[TBL] [Abstract][Full Text] [Related]
7. Proton pumping V-ATPase inhibitor bafilomycin A1 affects Rab7 lysosomal localization and abolishes anterograde trafficking of osteoclast secretory lysosomes.
Matsumoto N; Nakanishi-Matsui M
Biochem Biophys Res Commun; 2019 Mar; 510(3):421-426. PubMed ID: 30717974
[TBL] [Abstract][Full Text] [Related]
8. Bafilomycin A1 inhibits bone resorption and tooth eruption in vivo.
Sundquist KT; Marks SC
J Bone Miner Res; 1994 Oct; 9(10):1575-82. PubMed ID: 7817803
[TBL] [Abstract][Full Text] [Related]
9. Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R.
Liu S; Zhu W; Li S; Ma J; Zhang H; Li Z; Zhang L; Zhang B; Li Z; Liang X; Shi W
Int J Mol Med; 2016 Feb; 37(2):284-92. PubMed ID: 26647715
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of osteoclast vacuolar H(+)-ATPase.
Farina C; Gagliardi S
Curr Pharm Des; 2002; 8(23):2033-48. PubMed ID: 12171517
[TBL] [Abstract][Full Text] [Related]
11. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
Nyman JK; Väänänen HK
Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
[TBL] [Abstract][Full Text] [Related]
12. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
Mattsson JP; Keeling DJ
Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
[TBL] [Abstract][Full Text] [Related]
13. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.
Lees RL; Sabharwal VK; Heersche JN
Bone; 2001 Feb; 28(2):187-94. PubMed ID: 11182377
[TBL] [Abstract][Full Text] [Related]
14. Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.
Hiasa M; Okui T; Allette YM; Ripsch MS; Sun-Wada GH; Wakabayashi H; Roodman GD; White FA; Yoneda T
Cancer Res; 2017 Mar; 77(6):1283-1295. PubMed ID: 28254863
[TBL] [Abstract][Full Text] [Related]
15. [V-ATPase inhibitor baflomycine A1 inhibits bone resorption by osteoclast-like cells].
Zhao N; Yu S
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):436-9. PubMed ID: 11869558
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.
Xu J; Cheng T; Feng HT; Pavlos NJ; Zheng MH
Histol Histopathol; 2007 Apr; 22(4):443-54. PubMed ID: 17290355
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of silkworm vacuolar-type ATPase activity by its inhibitor Bafilomycin A1 induces caspase-dependent apoptosis in an embryonic cell line of silkworm.
Tan XY; Wang X; Liu QS; Xie XQ; Li Y; Li BQ; Li ZQ; Xia QY; Zhao P
Arch Insect Biochem Physiol; 2018 Nov; 99(3):e21507. PubMed ID: 30246413
[TBL] [Abstract][Full Text] [Related]
18. Osteoclasts play a part in pain due to the inflammation adjacent to bone.
Nagae M; Hiraga T; Wakabayashi H; Wang L; Iwata K; Yoneda T
Bone; 2006 Nov; 39(5):1107-1115. PubMed ID: 16769263
[TBL] [Abstract][Full Text] [Related]
19. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
Niikura K; Takano M; Sawada M
Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
Okahashi N; Nakamura I; Jimi E; Koide M; Suda T; Nishihara T
J Bone Miner Res; 1997 Jul; 12(7):1116-23. PubMed ID: 9200012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
